Now showing items 1-2 of 2

    • A new graphical format to communicate treatment effects to patients—A web-based randomized controlled trial 

      Kasper, Jürgen; van de Roemer, Adrian; Pöttgen, Jana; Rahn, Anne; Backhus, Imke; Bay, Yasemin; Köpke, Sascha; Heesen, Christoph (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-17)
      <p><i>Objective</i>: Patients making treatment decisions require understandable evidence‐based information. However, evidence on graphical presentation of benefits and side‐effects of medical treatments is not conclusive. The study evaluated a new space‐saving format, CLARIFIG (clarifying risk figures), aiming to facilitate accuracy of comprehension.</p> <p><i>Methods</i>: CLARIFIG displays ...
    • Risk knowledge in relapsing multiple sclerosis (RIKNO 1.0) - Development of an outcome instrument for educational interventions 

      Heesen, Christoph; Kasper, Jürgen; Fischer, Korbinan; Köpke, Sascha; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Vahter, Liina; Drulović, Jelena S.; Van Nunen, An; Beckmann, Yeşim Yetimalar; Liethmann, Katrin; Fulcher, Gary; Solari, Alessandra (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-10-02)
      Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few attempts have been made to develop assessment tools. Multiple Sclerosis (MS) is a chronic inflammatory disease of young adults with an increasing number of partially effective immunotherapies and therefore a paradigmatic disease to study patient involvement. <p>Objective/methods Based on an item ...